The Patent Finder
VB

Vivex Biologics Group, Inc.

First filing 2003
OverviewNotableFeesChangesFamiliesPatent listSources & methods

76 patents currently held

5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3 more records may belong here and await a decision; they are not counted.

The next term ends in May 2027. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
6
Ending by 2030
May 2027
Next term end
36
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Biological Composition in a Protectant Shroud and Methods US 11,160,904
Cited by 15 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2035. A terminal disclaimer caps this term to an earlier patent's.
Ends Apr 2035 · High confidence
Also notable
Compositions for Prevention of Adhesions and Other Barrier Applications US 9,162,005
The most cited patent in this portfolio, cited by 56 later US patents, top 10% of utility patents granted in 2015 in our data. Protection runs to 2030.
Ends Feb 2030 · Medium confidence
Also notable
Viable Disc Regenerative Composition and Method of Manufacture and Use US 11,324,215
Cited by 10 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2038.
Ends May 2038 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 9 to 11, 2026 · next Dec 9
  • 1 fee due Jan 23, 2027
    The maintenance fee for Malleable Demineralized Bone Composition and Method of Manufacture (US 10,357,593) comes due Jan 23, 2027. Unpaid by Jul 23, 2027, it lapses early.
  • 1 fee due Feb 28, 2027
    The maintenance fee for Infused Cartilage Particles (US 11,738,118) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
  • 2 fees due Mar 17, 2027
  • 1 fee due Apr 20, 2027
    The maintenance fee for Compositions for Prevention of Adhesions and Other Barrier Applications (US 9,162,005) comes due Apr 20, 2027. Unpaid by Oct 20, 2027, it lapses early.
  • 1 fee due May 5, 2027
    The maintenance fee for Moldable Bone Composition (US 10,463,767) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.
  • 1 fee due Jun 24, 2027
    The maintenance fee for Biologic Composition and Method of Manufacture (US 10,513,690) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.
  • 4 fees due Sep 5 to 24, 2027 · next Sep 5
  • 2 fees due Oct 19 to 26, 2027 · next Oct 19
  • 2 fees due Nov 12 to 17, 2027 · next Nov 12

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The largest of its 36 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 8,791,071Cartilage Material
In force
 · Medium confidence
In forceMedium confidence
US 8,940,692Cartilage Material
In force
 · Medium confidence
In forceMedium confidence
US 8,940,698Cartilage Material
In force
 · Medium confidence
In forceMedium confidence
US 9,433,702Cartilage Material
In force
 · Medium confidence
In forceMedium confidence
US 9,415,084Treatment of Leaky or Damaged Tight Junctions and Enhancing Extracellular Matrix
In force
 · High confidence
In forceHigh confidence
US 9,162,005Compositions for Prevention of Adhesions and Other Barrier Applications
In force
 · Medium confidence
In forceMedium confidence
US 9,314,330Fan Folded Fascia Lata for Cruciate Ligament Substitution and Method and Apparatus for Making the Same
In force
 · High confidence
In forceHigh confidence
US 9,320,761Bone Induction System and Methods
In force
 · High confidence
In forceHigh confidence
US 8,784,908Composition of a Bone Repair Mixture
In force
 · High confidence
In forceHigh confidence
US 8,936,816Composition of a Bone Repair Mixture
In force
 · High confidence
In forceHigh confidence
10 of 76 patents shown.
Pro members see all 76.
Pro members: see all 76 patents
Also on record, not counted in the 76: 5 patents in force now held by others · 7 patents ended · 16 applications pending · 16 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited